Treatment of ocular hypertension and glaucoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5575 (2006.01) A61K 31/557 (2006.01)

Patent

CA 2454422

The instant invention discloses a method for treatment of ocular hypertension and glaucoma, which comprises administrating topically to the eyes of a mammalian subject in need of such treatment more than 5 micrograms and less than 50 micrograms per eye per administration of 15-keto-prostaglandin compound having a ring structure at the end of the omega chain. The treatment of the present invention causes substantially no or reduced ophthalmic irritating side effect even in such a high dose.

Cette invention se rapporte à un procédé servant à traiter l'hypertension oculaire et les glaucomes et qui consiste à administrer en mode topique dans les yeux d'un sujet mammifère nécessitant un tel traitement plus de 5 µg et moins de 50 µg par oeil par administration d'un composé de 15-céto-prostaglandine comportant une structure cyclique à l'extrémité de la chaîne .omega.. Le traitement faisant l'objet de cette invention ne produit pour ainsi dire pas d'effets secondaires irritants l'oeil ou en produit à un niveau réduit, même à une telle dose élevée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of ocular hypertension and glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ocular hypertension and glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ocular hypertension and glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1825280

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.